BlackRock Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.7M Buy
60,785
+11,692
+24% +$519K ﹤0.01% 1327
2016
Q3
$1.77M Buy
49,093
+32,911
+203% +$1.19M ﹤0.01% 1472
2016
Q2
$222K Sell
16,182
-33,565
-67% -$460K ﹤0.01% 2506
2016
Q1
$955K Buy
49,747
+4,332
+10% +$83.2K ﹤0.01% 1722
2015
Q4
$1.59M Sell
45,415
-217,211
-83% -$7.6M ﹤0.01% 1479
2015
Q3
$24.2M Buy
262,626
+8,336
+3% +$767K 0.03% 468
2015
Q2
$22.3M Buy
254,290
+26,491
+12% +$2.33M 0.02% 484
2015
Q1
$16.9M Sell
227,799
-85,463
-27% -$6.34M 0.02% 607
2014
Q4
$17.5M Buy
313,262
+1,456
+0.5% +$81.5K 0.02% 584
2014
Q3
$14.1M Buy
311,806
+296,363
+1,919% +$13.4M 0.01% 657
2014
Q2
$639K Sell
15,443
-8,034
-34% -$332K ﹤0.01% 1796
2014
Q1
$1.63M Buy
23,477
+10,170
+76% +$704K ﹤0.01% 1243
2013
Q4
$802K Sell
13,307
-80,469
-86% -$4.85M ﹤0.01% 1647
2013
Q3
$5.7M Sell
93,776
-115,051
-55% -$6.99M 0.01% 935
2013
Q2
$14M Buy
+208,827
New +$14M 0.01% 654